In sporadic invasive breast cancers (IBC), we demonstrated that RECQL deficiency at the transcriptomic and proteomic levels are associated with aggressive breast cancer phenotypes and poor patient survival [6]. This evidence concerns the gene RECQL and inflammatory breast carcinoma.